BioForce Receives Key U.S. Patent Covering NanoArrayer.AMES, Iowa Ames is a city located in the central part of the U.S. state of Iowa, about 30 miles north of Des Moines in Story County. It is the principal city of the 'Ames, Iowa Metropolitan Statistical Area' which encompasses all of Story County, Iowa and which, when combined with the -- BioForce Nanosciences (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BFNH) received notice from the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. Patent and Trade Office of the March 7, 2006 issuance of patent number 7,008,769 entitled "Nanoscale Molecular Arrayer". This is the second patent issued to the Company in 2006. This patent covers key elements of the NanoArrayer(TM) System, a premier BioForce product line. The NanoArrayer(TM) System is a desktop molecular printing and surface patterning technology. Dr. Curtis Mosher A mosher is a person who is crossed between goth/punk/skater they have long hair and listen to music like slipknot and metal music. Some people call them headbangers. At certain music shows they have something called a mosh pit, basically its a fight pit with loads of people bashing each other. , Vice President of Research and Development at BioForce noted, "The NanoArrayer(TM) allows customers to design and print extremely small volumes of biomaterials and inorganic materials. This capability enables new developments in a broad spectrum of industries, including materials development, semiconductors, biotechnology, biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. diagnostics, and drug discovery. This technology also enables new business opportunities for Companies operating within these markets." Dr. Mosher is co-author of this patent. Company Founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Dr. Eric Henderson Eric Henderson (born January 8, 1983 in New Orleans, Louisiana) is a linebacker on the Cincinnati Bengals. He played college football at Georgia Tech, where he was part of a dominating Jon Tenuta defense. He was All-ACC first team in 2003, and All-ACC second team in 2004 and 2005. , the primary author of this patent said, "We are very pleased with the issuance of this key NanoArrayer(TM) patent. This patent is an important addition to our intellectual property portfolio, further strengthening our product position in the marketplace. BioForce has a very exciting agenda for 2006. We are currently focused on placing NanoArrayers(TM) with key opinion makers and leaders in various fields of research. We are also expanding our sales force and production capabilities for this key product line to meet the anticipated response from multiple markets." About BioForce Nanosciences, Inc. BioForce Nanosciences provides innovative and practical commercial products for applications in nanotechnology, with more than a decade of invention, research and development of patented and patent-pending products. The core technology is the NanoArrayer(TM) System, a proprietary platform for precision printing and surface patterning. The NanoArrayer(TM) System includes a consumable line of print cartridges and chip surfaces. This system enables new and important applications in the biomedical and life sciences markets. BioForce continues to target inventions that further expand the reach of its proprietary technology. The ViriChip(TM) System, a patented diagnostic device for rapid detection and identification of multiple viruses on a single chip, is an example of the Company's technology expansion program. BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) company brings inventions to the marketplace that complement existing innovations, licensing and acquisitions. BioForce is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of BioForce Nanosciences Holdings, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: BFNH.OB). For more information, visit www.bioforcenano.com or contact BioForce at info@bioforcenano.com or 515-233-8333. This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the company's most recent filings with the Securities and Exchange Commission. The company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion